CN Stock MarketDetailed Quotes
603669 Lionco Pharmaceutical Group
- 4.27
- -0.12-2.73%
Market Closed Oct 11 15:00 CST
3.08BMarket Cap-25266P/E (TTM)
4.37High4.20Low54.03KlotVolume4.37Open4.39Pre Close22.99MTurnover0.75%Turnover RatioLossP/E (Static)721.24MShares6.0752wk High3.87P/B3.08BFloat Cap2.9452wk Low4.83Limit Up721.24MShs Float20.05Historical High3.95Limit Down3.87%Amplitude2.94Historical Low--Dividend TTM4.26Avg Price29.88KlotAsk--Div YieldTTM100Lot Size22.01KlotBid
Lionco Pharmaceutical Group Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -34.49%111.49M | 9.25%71.72M | -20.87%305.4M | -19.03%224.14M | -6.89%170.19M | -49.25%65.65M | -56.37%385.95M | -63.56%276.84M | -65.23%182.79M | -51.45%129.35M |
| Refunds of taxes and levies | ---- | ---- | -99.66%34.76K | ---- | ---- | ---- | --10.08M | ---- | ---- | ---- |
| Cash received relating to other operating activities | 269.01%33.01M | 248.48%10.13M | 157.94%59.26M | 61.84%36.75M | -56.49%8.94M | 8.71%2.91M | -33.52%22.98M | -19.87%22.71M | -23.99%20.56M | 3.95%2.67M |
| Cash inflows from operating activities | -19.33%144.5M | 19.39%81.85M | -12.96%364.7M | -12.90%260.9M | -11.91%179.13M | -48.07%68.56M | -54.42%419M | -61.99%299.55M | -63.22%203.35M | -50.92%132.03M |
| Goods services cash paid | 30.19%94.49M | 137.20%59.62M | 40.87%156.34M | 82.29%107.3M | 118.34%72.58M | 98.92%25.14M | 0.47%110.98M | -39.20%58.86M | -24.88%33.24M | -43.98%12.64M |
| Staff behalf paid | -11.08%26.55M | -1.28%16.51M | -11.27%52.39M | -3.53%41.66M | -4.33%29.85M | 9.16%16.72M | -10.24%59.04M | -14.93%43.18M | -14.35%31.2M | -27.30%15.32M |
| All taxes paid | -58.15%3.76M | -46.68%2.46M | -57.21%13.47M | -63.91%10.25M | -58.80%8.98M | -60.67%4.61M | -61.86%31.47M | -58.81%28.39M | -55.24%21.79M | -61.00%11.73M |
| Cash paid relating to other operating activities | -38.10%57.91M | -38.55%23.94M | -36.46%180.38M | -41.19%122.84M | -0.13%93.55M | -40.22%38.96M | -46.64%283.87M | -63.86%208.88M | -75.31%93.68M | -59.42%65.16M |
| Cash outflows from operating activities | -10.86%182.7M | 20.02%102.53M | -17.06%402.57M | -16.88%282.05M | 13.92%204.96M | -18.52%85.43M | -38.62%485.36M | -57.29%339.31M | -64.64%179.91M | -55.25%104.85M |
| Net cash flows from operating activities | -47.91%-38.2M | -22.57%-20.67M | 42.92%-37.87M | 46.81%-21.15M | -210.21%-25.83M | -162.06%-16.87M | -151.64%-66.36M | -519.08%-39.76M | -46.69%23.44M | -21.77%27.18M |
| Investing cash flow | ||||||||||
| Cash received from returns on investments | -75.77%1.51M | -93.42%327.93K | -2.05%15.61M | 104.02%8.62M | 81.91%6.24M | 197.22%4.99M | -14.86%15.94M | -62.36%4.23M | -19.40%3.43M | 6.92%1.68M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 839.27%1.91M | ---- | -93.13%180.05K | 928.50%205.7K | 918.50%203.7K | --4.5K | 45,447.71%2.62M | 207.69%20K | --20K | ---- |
| Cash received relating to other investing activities | -69.92%137M | -72.85%87M | -23.32%1.02B | -47.93%590.44M | -43.94%455.44M | -32.53%320.44M | -21.73%1.33B | 3.08%1.13B | 45.08%812.46M | 89.98%474.95M |
| Cash inflows from investing activities | -69.60%140.42M | -73.17%87.33M | -23.20%1.03B | -47.34%599.27M | -43.39%461.89M | -31.72%325.43M | -21.50%1.35B | 2.42%1.14B | 44.60%815.91M | 89.46%476.63M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -51.74%7.79M | -71.36%4.11M | -46.00%23.13M | 25.34%20.93M | 144.89%16.15M | 491.24%14.35M | -21.85%42.84M | -24.92%16.7M | -60.02%6.59M | -80.75%2.43M |
| Cash paid to acquire investments | ---- | ---- | 0.00%30M | 0.00%30M | 0.00%30M | ---- | 1,400.00%30M | 1,400.00%30M | --30M | --30M |
| Cash paid relating to other investing activities | -99.54%2.53M | -99.52%2M | -9.55%1.03B | -33.47%638M | -24.52%548M | -15.32%420M | -45.41%1.14B | -43.25%959M | -36.32%726M | -36.41%496M |
| Cash outflows from investing activities | -98.26%10.33M | -98.59%6.11M | -10.60%1.09B | -31.50%688.93M | -22.09%594.15M | -17.80%434.35M | -43.46%1.21B | -41.33%1.01B | -34.06%762.59M | -33.33%528.43M |
| Net cash flows from investing activities | 198.37%130.1M | 174.57%81.22M | -139.45%-51.9M | -167.72%-89.66M | -348.07%-132.26M | -110.26%-108.91M | 130.39%131.54M | 121.95%132.39M | 109.00%53.31M | 90.43%-51.8M |
| Financing cash flow | ||||||||||
| Cash from borrowing | ---- | ---- | -42.78%117.35M | 13.09%117.35M | 13.78%117M | 100.00%100M | -57.27%205.11M | -78.38%103.77M | -68.84%102.83M | -37.50%50M |
| Cash received relating to other financing activities | 827.42%12M | --12M | -68.39%2.29M | -17.94%1.29M | 66.50%1.29M | ---- | 8.27%7.26M | -43.53%1.58M | --777.44K | --32.3K |
| Cash inflows from financing activities | -89.85%12M | -88.00%12M | -43.66%119.65M | 12.62%118.65M | 14.18%118.29M | 99.87%100M | -56.37%212.36M | -78.18%105.35M | -68.60%103.61M | -37.46%50.03M |
| Borrowing repayment | -4.86%100M | 100.00%100M | -62.34%205.26M | -80.71%105.11M | -76.38%105.11M | -54.55%50M | -9.10%545M | 76.57%545M | 110.70%445M | 10.00%110M |
| Dividend interest payment | -90.26%196.31K | -88.80%127.57K | -89.91%8.08M | -96.24%2.92M | -58.65%2.02M | 361.69%1.14M | -49.67%80.13M | -49.32%77.79M | -96.76%4.88M | -93.46%246.75K |
| Cash payments relating to other financing activities | -84.96%2.18M | -80.84%1.92M | 7.77%65.29M | -48.74%14.75M | -46.90%14.5M | -67.32%10M | 788.12%60.58M | 2,802.70%28.77M | 3,888.77%27.3M | 11,004.84%30.6M |
| Cash outflows from financing activities | -15.82%102.38M | 66.90%102.04M | -59.37%278.64M | -81.16%122.77M | -74.51%121.62M | -56.59%61.14M | -10.43%685.71M | 40.68%651.56M | 31.76%477.18M | 35.37%140.85M |
| Net cash flows from financing activities | -2,618.86%-90.37M | -331.71%-90.04M | 66.41%-158.99M | 99.24%-4.13M | 99.11%-3.32M | 142.79%38.86M | -69.72%-473.35M | -2,882.80%-546.21M | -1,061.62%-373.57M | -277.65%-90.81M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 100.95%1.53M | 66.06%-29.5M | 39.05%-248.76M | 74.66%-114.94M | 45.62%-161.41M | 24.70%-86.92M | 30.02%-408.16M | 23.09%-453.59M | 48.86%-296.82M | 78.23%-115.43M |
| Add:Begin period cash and cash equivalents | -44.17%314.45M | -44.43%312.43M | -42.02%563.21M | -42.02%563.21M | -42.02%563.21M | -42.12%562.18M | -37.52%971.37M | -37.52%971.37M | -37.52%971.37M | -37.52%971.37M |
| End period cash equivalent | -21.36%315.98M | -40.47%282.93M | -44.17%314.45M | -13.42%448.28M | -40.43%401.8M | -44.47%475.26M | -42.02%563.21M | -46.33%517.78M | -30.76%674.55M | -16.43%855.94M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data